Company intelligence / Profile preview

NeuroGlove

Ownership: Private
Development stage: Preclinical

Overview

NeuroGlove offers a revolutionary non-invasive therapy medical device that has been recognized for outstanding breakthrough contributions in medical device innovation. It has been launched globally with regional partnering agreements in GCC countries and India. The technology promises to treat a wide range of neurological conditions safely without invasive procedures. The founders have extensive clinical experience with over 10,000 evaluations and more than 6,000 complex brain surgeries between them.

Therapeutic areas: PsychiatryNeurology
Modalities: DeviceNon-invasive neuromodulation medical device technology
Industry: Therapeutic Medical Devices

Partnerships

Partnership with Dr Mansoor Al Obeidli and associated companies for GCC and India regional distribution.

Beyond the preview

Go deeper on NeuroGlove.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on NeuroGlove.

Explore the full profile